HLA class II diversity in HIV-1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial

The RV144 HIV vaccine trial in Thailand elicited antibody responses to the envelope of HIV-1, which correlated significantly with the risk of HIV-1 acquisition. Human leukocyte antigen (HLA) class II molecules are essential in antigen presentation to CD4 T cells for activation of B cells to produce...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Tissue Antigens
Main Authors: Baldwin, Karen M., Ehrenberg, Philip K., Geretz, Aviva, Prentice, Heather A., Nitayaphan, Sorachai, Rerks-Ngarm, Supachai, Kaewkungwal, Jaranit, Pitisuttithum, Punnee, O’Connell, Robert J., Kim, Jerome H., Thomas, Rasmi
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4552183/
https://ncbi.nlm.nih.gov/pubmed/25626602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tan.12507
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki